Top Sell
| Security | Buy | Sell ▲ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Merck KGaA | 3 | 1 | 0 | 0 | €152.60 | €146.00 | -4.325% |
| Evotec SE | 4 | 1 | 0 | 0 | €9.83 | €21.50 | 118.830% |
| Acadia Pharmaceuticals | 23 | 1 | 3 | 1 | €15.62 | €32.59 | 108.678% |
| Vaxart Inc. | 1 | 1 | 1 | 1 | €0.69 | - | - |
| Aspira Womens Health Inc. | 0 | 1 | 0 | 0 | €2.92 | - | - |
| Ironwood Pharmaceuticals | 7 | 1 | 0 | 0 | €7.70 | €19.32 | 150.964% |
| Grifols S.A. ADR | 0 | 1 | 0 | 0 | €5.90 | - | - |
| Chimerix Inc. | 4 | 1 | 0 | 0 | €0.92 | €5.51 | 497.465% |
| Eagle Pharmaceuticals Inc | 0 | 1 | 0 | 0 | €3.84 | - | - |
| Carbylan Therapeutics Inc | 1 | 1 | 0 | 0 | €9.80 | €22.00 | 124.490% |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 2 | 0 | €35.60 | €50.00 | 40.449% |
| Corvus Pharmaceuticals Inc | 4 | 1 | 0 | 1 | €1.44 | €5.10 | 253.377% |
| Immuron | 0 | 1 | 0 | 1 | €2.16 | - | - |
| Karyopharm Therapeutics Inc. | 7 | 2 | 0 | 0 | €1.03 | €3.65 | 255.694% |
| BioLine RX Ltd ADR | 0 | 2 | 0 | 0 | €0.62 | - | - |
| Cytomx Therapeutics Inc | 2 | 2 | 2 | 2 | €4.15 | €50.00 | 1104.819% |
| Nymox Pharmaceutical Corp. | 0 | 2 | 0 | 0 | €0.23 | - | - |
| Novavax Inc. | 3 | 2 | 0 | 0 | €4.44 | €12.00 | 170.514% |
| Agenus Inc. | 2 | 2 | 0 | 0 | €0.41 | €7.30 | 1664.911% |
| Coherus Bioscien. | 2 | 2 | 0 | 0 | €2.02 | €3.00 | 48.588% |
| Anavex Life Sciences Corp | 0 | 2 | 0 | 0 | €3.50 | - | - |
| Bristol-Myers Squibb | 11 | 3 | 1 | 0 | €40.80 | €67.64 | 65.782% |
| Atara Biotherapeutics Inc. | 2 | 3 | 0 | 0 | €0.62 | €3.00 | 380.769% |
| Sage Therapeutics Inc. | 5 | 3 | 1 | 1 | €12.22 | €26.71 | 118.705% |
| Omeros Corp. | 2 | 4 | 0 | 0 | €3.42 | - | - |